Efficacy of bacillus Calmette-Guérin and isoniazid-resistant bacillus Calmette-Guérin with and without isoniazid chemoprophylaxis from day of vaccination. II. Field trial in man.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage; D001431:Bacteriological Techniques; D002452:Cell Count; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007223:Infant; D007231:Infant, Newborn; D007538:Isoniazid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009163:Mycobacterium bovis / Q000187:drug effects / Q000276:immunology*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000517:prevention & control*
D001500:BCG Vaccine; D007538:Isoniazid